How much funding has PHASE GENOMICS, INC. raised?

PHASE GENOMICS, INC. has raised $4.0M in total funding, most recently a grant round.

When was PHASE GENOMICS, INC. founded?

PHASE GENOMICS, INC. was founded in 2016.

Where is PHASE GENOMICS, INC. headquartered?

PHASE GENOMICS, INC. is headquartered in SEATTLE, Washington, United States.

What industry is PHASE GENOMICS, INC. in?

PHASE GENOMICS, INC. operates in Biotech, Developer Tools, Healthcare.

How many employees does PHASE GENOMICS, INC. have?

PHASE GENOMICS, INC. has 1-10 employees.

PHASE GENOMICS, INC.

Q: Who are PHASE GENOMICS, INC.'s investors?

PHASE GENOMICS, INC.'s investors include Bill & Melinda Gates Foundation, National Cancer Institute, Alliance of Angels.

Blueprints for Biology

SEATTLE, United States · Founded 2016 · $4.0M raised

Biotech

Developer Tools

Healthcare

Headquarters: SEATTLE, Washington
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: phasegenomics.com
Total Funding: $4.0M
Last Round: $1.5M GrantMar 2024
Rounds: 3

About

Phase Genomics is a life science company that develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing, enabling chromosome-scale genome assembly, metagenomic deconvolution, and structural variant analysis. The company offers laboratory kits for plants, animals, microbes, and human samples alongside industry-leading bioinformatics software platforms including CytoTerra, ProxiMeta, and Proximo. Founded in 2015 in Seattle, Phase Genomics serves applications in oncology, genetic disease, metagenomics, and microbiology.

Summary

PHASE GENOMICS, INC. is a Biotech company based in SEATTLE, United States, founded in 2016. It has raised $4.0M in total across 3 rounds, most recently a $1.5M Grant round in Mar 2024. Investors include Bill & Melinda Gates Foundation, National Cancer Institute and Alliance of Angels.

LinkedIn X (Twitter)